Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia | Haematologica
![Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic hemopoietic stem cell transplantation Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic hemopoietic stem cell transplantation](https://gvhdhub.com/media/images_resized/34/dc/shutterstock-700277188[ogImageMetaTag].jpg)
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic hemopoietic stem cell transplantation
![Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (TFRC) Deficiency - The Journal of Allergy and Clinical Immunology: In Practice Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (TFRC) Deficiency - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8ebea527-c3d7-4dab-9d20-2b040aed8f96/gr1.jpg)
Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (TFRC) Deficiency - The Journal of Allergy and Clinical Immunology: In Practice
![PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine](https://www.researchgate.net/publication/317129185/figure/fig1/AS:498185873391616@1495788176053/Only-blood-transfusion-in-mouse-model-showed-no-TA-GVHD-Recipients-were-transfused-1ml_Q320.jpg)
PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine
![Acute Kidney Injury and Nephrotic-Range Proteinuria in a Patient 18 Months After Bone Marrow Transplantation - American Journal of Kidney Diseases Acute Kidney Injury and Nephrotic-Range Proteinuria in a Patient 18 Months After Bone Marrow Transplantation - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3bed142a-8485-4463-ae73-d66281d0c34f/gr1_lrg.jpg)